SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000884731-17-000017
Filing Date
2017-02-02
Accepted
2017-02-02 16:41:58
Documents
5
Period of Report
2017-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148607170166256.html 4  
1 FORM 4 wf-form4_148607170166256.xml 4 7683
2 APRIL 2016 april2016clackson001.jpg GRAPHIC 196992
3 CLACKSON INACTIVE timclackson.htm EX-24 603
4 APRIL 2016 april2016clackson.htm EX-24 624
5 CLACKSON POA timclackson001.jpg GRAPHIC 212977
  Complete submission text file 0000884731-17-000017.txt   575295
Mailing Address 125 BINNEY STREET CAMBRIDGE MA 02142
Business Address 125 BINNEY STREET CAMBRIDGE MA 02142 6174940400
ARIAD PHARMACEUTICALS INC (Issuer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARIAD PHARMACEUTICALS INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
CLACKSON TIMOTHY P (Reporting) CIK: 0001242992 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36172 | Film No.: 17568869